Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
- DOI
- 10.4081/ejh.2025.4172
- Published
- 2025-02-11
- Container
- European Journal of Histochemistry
- Publisher
- PAGEPress Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4081/ejh.2025.4172,
title = {Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups},
author = {Mohamed O. Andarawi and Hassan Otifi and Hesham Hassan and Adil A. Yousif and Saadalnour A. Mustafa and Shawgi A. Elsiddig and Asad Ma Babker and Elryah I. Ali and Omer Osman Elhag},
year = {2025},
journal = {European Journal of Histochemistry},
doi = {10.4081/ejh.2025.4172},
url = {https://doi.org/10.4081/ejh.2025.4172}
}RIS
TY - JOUR TI - Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups AU - Mohamed O. Andarawi AU - Hassan Otifi AU - Hesham Hassan AU - Adil A. Yousif AU - Saadalnour A. Mustafa AU - Shawgi A. Elsiddig AU - Asad Ma Babker AU - Elryah I. Ali AU - Omer Osman Elhag PY - 2025 JO - European Journal of Histochemistry DO - 10.4081/ejh.2025.4172 UR - https://doi.org/10.4081/ejh.2025.4172 ER -
APA
Andarawi, M. O., Otifi, H., Hassan, H., Yousif, A. A., Mustafa, S. A., Elsiddig, S. A., Babker, A. M., Ali, E. I., & Elhag, O. O. (2025). Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2025.4172
Source records
- crossref · retrieved 2026-09-25T17:02:38.683Z